Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

2.

Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM.

Arch Intern Med. 2002 Jan 28;162(2):209-16.

PMID:
11802755
3.

Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.

Harati H, Hadaegh F, Tohidi M, Azizi F.

Diabetes Res Clin Pract. 2009 Jul;85(1):90-5. doi: 10.1016/j.diabres.2009.04.006. Epub 2009 May 2.

PMID:
19414206
4.

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW.

Arch Intern Med. 2002 Dec 9-23;162(22):2597-604.

PMID:
12456232
5.

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.

Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC.

Arch Intern Med. 2005 Jan 24;165(2):227-33.

PMID:
15668371
6.

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.

Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study.

Diabetes Care. 2002 Oct;25(10):1845-50.

PMID:
12351489
8.

Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.

Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, Hulley S, Barrett-Connor E.

Ann Intern Med. 2005 May 17;142(10):813-20.

PMID:
15897531
9.

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S; HOPE investigators.

Diabetologia. 2005 Sep;48(9):1749-55. Epub 2005 Jul 30.

PMID:
16059716
10.

Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.

Lin L, Chen G, Zou X, Zhao J, Zhu F, Tu M, Xu S, Lin W, Yang S, Zhang Y, Lin M, Chen N, Huang H, Liang J, Li L, Yao J.

Obes Rev. 2009 Jul;10(4):420-30. doi: 10.1111/j.1467-789X.2009.00600.x. Epub 2009 May 12.

PMID:
19460110
11.

Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

Ferrannini E, Massari M, Nannipieri M, Natali A, Ridaura RL, Gonzales-Villalpando C.

Diabetologia. 2009 May;52(5):818-24. doi: 10.1007/s00125-009-1289-8. Epub 2009 Feb 18.

PMID:
19224196
12.

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Unwin N, Shaw J, Zimmet P, Alberti KG.

Diabet Med. 2002 Sep;19(9):708-23. Review.

PMID:
12207806
13.

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.

Qiao Q, Pyörälä K, Pyörälä M, Nissinen A, Lindström J, Tilvis R, Tuomilehto J.

Eur Heart J. 2002 Aug;23(16):1267-75.

PMID:
12175663
14.

Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.

Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL.

Diabetes Care. 2001 Aug;24(8):1397-402.

PMID:
11473076
15.

Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.

Andreozzi F, Succurro E, Mancuso MR, Perticone M, Sciacqua A, Perticone F, Sesti G.

Diabetes Metab Res Rev. 2007 Oct;23(7):547-50.

PMID:
17311284
16.

Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.

Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

Diabetes Care. 2001 Jan;24(1):39-44.

PMID:
11194238
17.

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A.

Diabetes Care. 1999 Jun;22(6):920-4.

18.

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L.

Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. Epub 2007 Jun 29. Review.

PMID:
17601626
19.

Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL.

Arch Intern Med. 1999 Oct 11;159(18):2151-9.

PMID:
10527292

Supplemental Content

Support Center